Masked hypertension: a systematic review
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
The purpose of this research was to review the literature on masked hypertension. Studies, reviews and editorials on masked hypertension were identified by PubMed, Pascal BioMed and Cochrane literature systematic searches. Then, we carried out a meta-analysis of the six cohort studies reporting quantitative data for masked hypertension prognosis. There is still no clear consensus definition of masked hypertension and the reproducibility of the phenomenon is unknown. Nevertheless, the prevalence of masked hypertension seems to lie between 8 and 20%, and can be up to 50% in treated hypertensive patients. Subjects with masked hypertension have a higher risk of cardiovascular accidents [hazard ratios: 1.92 (1.51-2.44)] than normotensive subjects. This is due to a possible failure to recognize and appropriately manage this particular form of hypertension, the frequent association with other risk factors and coexisting target organ damage. The remaining unresolved questions are as follows: is masked hypertension a clinical entity that requires identification and characterization or a statistical phenomenon linked to the variability of blood pressure measurements?; because screening of the entire population is not feasible, how to identify individuals with masked hypertension?; and, in the absence of randomized trial, how to treat masked hypertension?
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“conventional methods of BP assessment conducted in a clinical (office-based) setting at rest fail to identify all cases of high BP, with 8–20% of individuals with normal clinic BP having raised out-of-clinic BP (i.e., masked uncontrolled hypertension).”
From The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance (2022) · cites this paper as [4]
In the citing paper
“and may occur in up to 20% of the general population [4], with greater prevalence in those with established disease, such as type 2 diabetes (>30%) [31].”
From The Identification and Management of High Blood Pressure Using Exercise Blood Pressure: Current Evidence and Practical Guidance (2022) · cites this paper as [4]
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655
Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227
Prognostic Value of Ambulatory Blood-Pressure Recordings in Patients with Treated Hypertension
Clement, D. L., De Buyzere, M. L., De Bacquer, D. A., de Leeuw, P. W., Duprez, D. A., Fagard, R. H., Gheeraert, P. J., Missault, L. H., Braun, J. J., Six, R. O., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022273 · Cited by 1,085
Bobrie, G. (2004) · JAMA · doi:10.1001/jama.291.11.1342 · Cited by 842
Self-citationA general parametric approach to the meta‐analysis of randomized clinical trials
Whitehead, A., & Whitehead, J. (1991) · Statistics in Medicine · doi:10.1002/sim.4780101105 · Cited by 750
Ohkubo, T., Imai, Y., Tsuji, I., Nagai, K., Kato, J., Kikuchi, N., Nishiyama, A., Aihara, A., Sekino, M., Kikuya, M., et al. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816070-00010 · Cited by 741
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., Parati, G., et al. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000163132.84890.c4 · Cited by 722
Mancia, G., Facchetti, R., Bombelli, M., Grassi, G., & Sega, R. (2006) · Hypertension · doi:10.1161/01.hyp.0000215363.69793.bb · Cited by 691
Research works printed but not linked: 3
- OBrien, 2003, on behalf of the European Society of Hypertension Working Group on blood pressure monitoring., J Hypertens, 21, 821
- Larkin, 1998, Isolated clinic hypertension and normotension: false positives and false negatives in the assessment of hypertension, Blood Press Monit, 3, 247
- OBrien, 2005, on behalf of the European Society of Hypertension Working Group on Blood Pressure Monitoring., J Hypertens, 23, 697
Cited by
Items 201–279 of 279
Grezzana, G. B., Stein, A. T., & Pellanda, L. C. (2017) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000238 · Cited by 3
Masked arterial hypertension: what is known and what expected to be learned?
Gorshkov, A. Y., Александрович, Ф. А., & Drapkina, O. M. (2020) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202023062143 · Cited by 4
Смирнова, М. И., Платонова, Е. М., An, B., Gorbunov, V. M., Деев, А. Д., & Koshelyaevskaya, Y. N. (2014) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2014-10-5-481-487 · Cited by 3
Billy-Brissac, R., Phiraî, S., Larifla, L., Atallah, A., Hédreville, M., Hedreville, S., Fassih, M., Cadélis, G., Rhinan, P., Soter, V., et al. (2015) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2015.04.010 · Cited by 3
Mesures de la pression artérielle
Amar, J., Bénétos, A., Blacher, J., Bobrie, G., Chamontin, B., Girerd, X. J., Halimi, J., Herpin, D., Mounier‐Véhier, C., Mourad, J., et al. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70431-5 · Cited by 4
“[4] Bobrie G, Clerson P, Ménard J, et al.”
BackgroundSelf-citationMasked inefficacy of arterial hypertension treatment: prevalence and predictors
Смирнова, М. И., Оганов, Р. Г., Gorbunov, V. M., Деев, А. Д., & Фатиховна, А. Г. (2011) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2011-6-11-17 · Cited by 3
Faye, M., Faye, M., Lemrabott, A. T., Cissé, M. M., Fall, K., Keita, A. I., Mbengue, M., Bâ, B., Keïta, N., Diagne, S., et al. (2019) · Saudi Journal of Kidney Diseases and Transplantation · doi:10.4103/1319-2442.270258 · Cited by 3
“in the general population (8%–48%).(7) It also confirms the figures of 5%–70% in advanced chronic kidney disease patients observed by Agarwal.”
ResultGorbunov, V. M., & Смирнова, М. И. (2009) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2009-5-3-76-82 · Cited by 5
Masked Hypertension and Obesity in Renal Transplant Recipients
Şaşak, G., & Ecder, S. A. (2019) · Transplantation Proceedings · doi:10.1016/j.transproceed.2019.01.175 · Cited by 3
Relentless Progression Toward Sustained Hypertension
Messerli, F. H., & Makani, H. J. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.132936 · Cited by 3
Frequency of masked hypertension and its relation to target organ damage in the heart
Algamal, A. M. (2015) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2015.06.003 · Cited by 2
Claisse, G., Maldonado, P., Kpogbemabou, N., Boudghene-Stambouli, F., Delsart, P., Devos, P., & Mounier‐Véhier, C. (2015) · Journal des Maladies Vasculaires · doi:10.1016/j.jmv.2014.12.008 · Cited by 2
Abbasi, M.-R., Lessan‐Pezeshki, M., Najafi, M.-T., Gatmiri, S. M., Karbakhsh, M., & Mohebi-Nejad, A. (2014) · Renal Failure · doi:10.3109/0886022x.2014.883933 · Cited by 3
Masked Uncontrolled Hypertension in the Elderly: A Dangerous Affair
Omboni, S. (2017) · American Journal of Hypertension · doi:10.1093/ajh/hpx136 · Cited by 2
Смирнова, М. И., Gorbunov, V. M., Boytsov, S. A., Loukianov, М. М., Калинина, А. М., Volkov, D., Деев, А. Д., Koshelyaevskaya, Y. N., & Белова, Е. Н. (2017) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2017-13-5-578-589 · Cited by 2
“Это подтверждают и проспективные исследования, посвященные оценке исходов при разных фенотипах АД, – риск инфаркта миокарда, мозгового инсульта, летальных исходов и других сердечно-сосудистых осложнений при скрытой АГ значимо выше, чем при нормотонии и эффективной АГТ, а также сопоставим с риском при устойчивой АГ [7,…”
ResultWhite-coat hypertension and masked hypertension: an update
Artom, N., Salvo, F., & Camardella, F. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.2015.662 · Cited by 3
Pandit, P., Patil, R., Palwe, V., Tambade, S. H., Wagh, S. Y., Gavit, M. K., & Nagarkar, R. V. (2020) · Head & Neck · doi:10.1002/hed.26590 · Cited by 3
“White-coat hypertension (WCH) refers to the untreated condition in which BP is elevated in the doctor's office, but is normal when measured by ambulatory and/or home blood pressure monitoring.(10)”
BackgroundImpact of Office and Ambulatory Blood Pressure on Mortality in Patients with Coronary Heart Disease
de la Sierra, A., Vinyoles, E., Gorostidi, M., Segura, J., & Ruilope, L. M. (2025) · Cardiology and Therapy · doi:10.1007/s40119-025-00437-1 · Cited by 1
“In addition, other ABPM-derived parameters, such as BP phenotypes [5, 7–9], nocturnal dip [10, 11], or short-term variability [12, 13] have additional prognostic importance in individuals with hypertension.”
How to screen and diagnose hypertension
Stergiou, G. S., Bilo, G., Camafort, M., de la Sierra, A., Κόλλιας, Α., Palatini, P., & Parati, G. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf674 · Cited by 4
Machine learning model for detecting masked hypertension in young adults
Miller, B., Coeyman, S. J., Wentzel, A., Mels, C. M. C., & Richardson, W. J. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1684693 · Cited by 2
Way, K. L., Roberts, T., Terada, T., Vidal‐Almela, S., O’Neill, C. D., Thomas, H. J., Parker, L., O’Gorman, S. A., Kaur, G., Keske, M. A., et al. (2026) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2026.04.001 · Cited by 2
High normal blood pressure: to treat or not to treat?
Ahmed, A., & Senior, R. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.24 · Cited by 2
Poirier, L., & Drouin, D. (2009) · Néphrologie & Thérapeutique · doi:10.1016/s1769-7255(09)74553-5 · Cited by 1
Ago, R., Nakashima, A., Naito, T., Doi, S., Ochiai, M., Hamaguchi, N., Yokoyama, Y., Tanaka, J., Yorioka, N., Masaki, T., et al. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0639-x · Cited by 1
“There are no previous reports of masked HT in HD patients, although there is evidence that the prevalence of masked HT is between 8 and 20 % in treated HT patients [25], and between 26 and 29 % in patients with CKD [26].”
BackgroundGermino, F. W. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12297 · Cited by 1
“Its incidence in some studies mirrors that of white-coat hypertension.(4) Yet, masked hypertension remains obscure, if not unknown, to many practitioners as well as patients.”
ResultLong-term variability of blood pressure and risk factors in men with stress-induced hypertension
Pg, K., & Осипова, И. Л. (2014) · CyberLeninK (CyberLeninka) · Cited by 1
Arterial hypertension: Unmasking the real risk
Salvetti, M., & Paini, A. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13179
Evaluation of Hypertension in Living Donor Candidates
Doshi, M. D., & Taler, S. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-53618-3_5 · Cited by 2
Balcı, C., Eşme, M., Sümer, F., Asıl, S., Yavuz, B., Tuna, R., Özsürekçi, C., Çalışkan, H., Ünsal, P., Ayçiçek, G. Ş., et al. (2021) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000532 · Cited by 1
Risk factors of cardiovascular pathology developing in medical professionals of surgical profile
Shapoval, N. S., Strizhakov, L. A., & Xazova, O. A. (2021) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20212405129 · Cited by 1
Epidemiology of Hypertension in Children
Awazu, M. (2014) · Springer eBooks · doi:10.1007/978-3-642-27843-3_54-1 · Cited by 1
Management of the Hypertensive Child
Ellis, D., & Miyashita, Y. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_82 · Cited by 1
Home blood pressure monitoring in hypertension
Lambie, J. (2014) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2014.9.1.13 · Cited by 1
Management of Hypertension in Athletes
Adamuz, C. (2016) · Wiley eBooks · doi:10.1002/9781119046899.ch39 · Cited by 2
Curie, M., Epidémiologie, S., Cacciolati, C., Berr, C., Guillaume, M., Pascal, M., Examinateur, A., Jean-michel, M., Examinateur, M., Jean-jacques, M., et al. (2005) · Revue du Rhumatisme · doi:10.1016/j.rhum.2005.10.003 · Cited by 1
Cacciolati, C. (2012) · HAL · Cited by 1
Clinical Significance and Treatment Requirements in White Coat and Masked Hypertension
Mallion, J.-M. (2012) · Springer eBooks · doi:10.1007/978-88-470-2601-8_2
“More recently, in a meta-analysis of six cohort studies reporting quantitative data for MH prognosis, Bobrie and colleagues [52] showed that subjects with MH have a higher risk of CV incidents [hazard ratios: 1.”
BackgroundHypertension artérielle et polykystose rénale autosomique dominante
Lorthioir, A. (2012) · OpenGrey (Institut de l'Information Scientifique et Technique)
Hipertensión arterial enmascarada. Más preguntas que respuestas
del Rey, R. H. (2009) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(09)71433-3
Flashes d’actualité - HTA/Vasculaire
Vaisse, B., Lantelme, P., Girerd, X. J., Azizi, M., Mourad, J., Baguet, J.-P., & Sabouret, R. P. P. (2011) · Archives des Maladies du Coeur et des Vaisseaux - Pratique · doi:10.1016/s1261-694x(11)70004-9
Lazzarini, D., & Ioli, G. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2015/12462
“In the literature [23], you can find some open questions regarding the management of MH (is it a clinical entity or a statistical phenomenon linked to the variability of blood pressure measurements?) but certainly data from the PAMELA study [8] revealed that MH is not prognostically innocent about the hazard ratio for…”
Backgroundde Tuero, G. C. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12317
“The uncontrolled ambulatory or out-of-office BP is a clinical situation that is attracting growing interest because of the association with an increased presence of subclinical cardiovascular disease, with cardiovascular morbidity and mortality, and with increased total mortality.(8,9) Importantly, home BP measurement…”
BackgroundKim, Y., Lee, H. M., Seo, J. Y., Kim, Y. S., Kim, B. K., Kim, M. K., Choi, B. Y., & Shin, J. (2011) · Journal of the Korean Society of Hypertension · doi:10.5646/jksh.2011.17.4.166
Acute, ambulatory and central blood pressure measurements in diabetes
Wijkman, M. O. (2012) · DiVA (Digitala Vetenskapliga Arkivet)
de Tuero, G. C. (2010) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Kjeldsen, S. E., Aksnes, T. A., Fagard, R. H., & Mancia, G. (2009)
KARŠTIS IR ŠIRDIES–KRAUJAGYSLIŲ SISTEMA. PERKAITIMO PREVENCIJA
Biliukas, M., & Karpavičienė, V. (2014) · Medicinos teorija ir praktika · doi:10.15591/mtp.2014.054
Sabater‐Hernández, D., Fikri‐Benbrahim, N., Azpilicueta, I., & Fikri-Benbrahim, O. (2011)
Passive Smoking and Masked Hypertension
Pierdomenico, S. D. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.99 · Cited by 1
Current Diagnosis and Treatment of Systemic Hypertension
Tekin, G. (2016) · Arşiv Kaynak Tarama Dergisi · doi:10.17827/aktd.196014 · Cited by 1
Ambulante 24-h-Langzeitblutdruckmessung
Lüders, S., Dechend, R., Eckert, S., Mengden, T., Nürnberger, J., Tholl, U., & Sanner, B. M. (2014) · CME · doi:10.1007/s11298-014-1202-8
Machado, A., de Paiva, G., Goulart, M. O. F., Gomes, M. A. M., & Vasconcelos, S. M. L. (2010)
Research Article Does masked hypertension impact left ventricular deformation
Tadic, M. V., Cuspidi, C., Vukomanovic, V., Celic, V. P., Tasic, I. S., Stevanović, A., & Kocijancic, V. (2016)
Aber ich bin doch gar nicht krank...
Trenkwalder, P. (2017) · CardioVasc · doi:10.1007/s15027-017-1272-0
“Insgesamt haben Patienten mit maskierter Hypertonie ein höheres Risiko für kardiovaskuläre Ereignisse [3] und wie in unserem Fall, häu©ger bereits Endorganschäden (vgl. obige NMR-Befunde).”
BackgroundInfluentialKim, S. M., Shim, I. K., Lee, J. W., Lee, J. Y., Lee, S. W., Cho, K. I., Kim, H. S., Lee, J., & Heo, J. H. (2017) · Kosin Medical Journal · doi:10.7180/kmj.2017.32.2.179
“Using both OBP and ABP, 4 groups of patients were identified: (1) normotensive patients (NT, both OBP and ABP were normal); (2) white coat hypertensives (WCHT, OBP was high, but ABP was normal); (3) masked hypertensives (MHT, OBP was normal, but ABP was high); and (4) sustained hypertensives (SHT, both OBP and ABP wer…”
BackgroundBobrie, G. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31376-7
Self-citationWitkowska, M., Naumczyk, P., Jodzio, K., Sabisz, A., Graff, B., Gąsecki, D., Szurowska, E., & Narkiewicz, K. (2019) · Polish Psychological Bulletin · doi:10.24425/ppb.2019.126029
“The changes to the vascular system lead to numerous (both immediate and long-term) pathologies of cerebral circulation (Kuo et al., 2005), which in turn increase the risk of a cerebrovascular accident, etc. (Bobrie et al., 2008; Verberk, Kessels, de Leeuw, 2008).”
BackgroundMaked hypertension - what we know about this disease
Pokorná, L. Š. M. S. O. M. T., Sovová, E., Masný, O., Pokorná, T., & Sovová, E. (2018) · Medicína pro praxi · doi:10.36290/med.2018.016
The prevalence of masked hypertension in a group of young healthy soldiers
Abuosa, A. M., Kinsara, A. J., Elshiekh, A. H., & Abrar, M. B. (2020) · Minerva Cardiology and Angiology · doi:10.23736/s0026-4725.20.05288-3
White-Coat Hypertension: Do We Really Understand It Now?
Ruilope, L. M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1982-6_11
Management of the Hypertensive Child
Ellis, D., & Miyashita, Y. (2014) · Springer eBooks · doi:10.1007/978-3-642-27843-3_82-1
Hypertension in the Kidney Transplant Recipient
Wadei, H. M., & Textor, S. C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0342-9_20 · Cited by 1
Hypertension and Chronic Kidney Disease – An Unhappy Marriage
Feldman, H. A. (2022) · Physician Assistant Clinics · doi:10.1016/j.cpha.2021.11.003 · Cited by 1
Kjeldsen, S. E., Aksnes, T. A., Fagard, R. H., & Mancia, G. (2009) · doi:10.1093/med/9780199566990.003.013 · Cited by 2
Cepeda, M., Hubbard, D. M., Oparil, S., Schwartz, J. E., Jaeger, B. C., Hardy, S. T., Medina, J., Chen, L., Muntner, P., & Shimbo, D. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-058140
Maskeli Hipertansiyon ve P Dalga Dispersiyonu Arasındaki İlişkinin Değerlendirilmesi
Çalışkan, S., Atay, M., & Altun, Ş. (2023) · Harran Üniversitesi Tıp Fakültesi Dergisi · doi:10.35440/hutfd.1127459
dos Santos, J., Meira, K. C., Coelho, J. C., & Pierin, Â. M. G. (2023) · Contribuciones a las Ciencias Sociales · doi:10.55905/revconv.16n.6-017
Giampá, S. Q. D. C. (2023) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2023.tde-29082023-121739 · Cited by 2
Маскована гіпертензія як фактор високого ризику серцево-судинних захворювань і смертності
Skybchyk, V. А., & Pylypiv, О. S. (2023) · HYPERTENSION · doi:10.22141/2224-1485.16.3-4.2023.354
Lima, L. P. H., Fróis, L. D. S., Dorneles, R. C. D., Fonseca, D. D. S., Farias, M. D. O., & Neto, C. R. D. S. (2024) · Research Society and Development · doi:10.33448/rsd-v13i3.45277
Stress-induced arterial hypertension: search for predictors
Ambatiello, L. G., Bravaya, A. I., Рогоза, А. Н., & Chazova, I. E. (2024) · Systemic Hypertension · doi:10.38109/2075-082x-2024-2-5-13
Clinical characterization of blood pressure phenotypes: the BP phenotype score
Al‐Mohaissen, M. A., Zohaifi, M. A. A., Lee, T., Almalki, N. A., Aleiban, H., & Al-Mehisen, R. (2025) · Blood Pressure · doi:10.1080/08037051.2025.2486284
“Office assessment alone has major accuracy limitations [8,9]; out-of-office evaluation of the entire office-hypertensive [10], and normotensive [4,11] populations is not feasible; and the current recommendations for out-of-office BP assessment [1,3] are not rigorous enough and may overlook many…”
Haq, S., Jamaal, V., Gupta, A. K., & Gupta, A. (2025) · PARIPEX-INDIAN JOURNAL OF RESEARCH · doi:10.36106/paripex/3400828
Barochiner, J. (2019) · Revista del Hospital Italiano de Buenos Aires · doi:10.51987/rev.hosp.ital.b.aires.v39i3.516
Central BP Monitoring, Home BP Monitoring, Ambulatory BP Monitoring in CKD
Cohen, D. L., Huan, Y., & Townsend, R. R. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1982-6_2
“Conversely, masked hypertension has been shown to be present in up to 20 % of a broad range of patients with CKD [66, 67].”
BackgroundLiu, Q., Li, N., Han, Q., Yuanyuan, Y. C. C., Sun, N., Wu, S., & Yu, J. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004296
Transparent approach based on deep learning and multiagent argumentation for hypertension management
Sendi, N. (2020) · theses.fr (ABES) · doi:10.70675/287e3bf5z984az4b7azbffaz0e578f463977
Hacıyeva, Y., & Əhmədova, C. (2026) · İctimai sağlamlıq · doi:10.33864/3105-7020.2026.n1.23-33
Predictors of insufficient response to initial antihypertensive treatment
Troshina, A. A., Колесникова, И. А., Kotovskaya, Y. V., Моисеев, В. С., & Kobalava, Z. D. (2011) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2011-17-6-525-530
Metadata
- Authors
- Bobrie, G., Clerson, P., Ménard, J., Postel-Vinay, N., Chatellier, G., & Plouin, P.-F.
- Affiliations
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Paris Descartes (FR)
- Corresponding author
- Bobrie, Guillaume
- Venue
- Journal of Hypertension
- Published
- 2008-09
- Volume
- 26
- Issue
- 9
- Pages
- 1715-1725
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1987521955
- Cited by
- 279
- References
- 64
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 4 · 2023: 9 · 2022: 11 · 2021: 10 · 2020: 20 · 2019: 19 · 2018: 14 · 2017: 8 · 2016: 21 · 2015: 24 · 2014: 36 · 2013: 25 · 2012: 15
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- masked hypertension, hypertension, cardiovascular risk, cardiovascular events, prevalence, target organ damage, blood pressure measurement variability, hypertension screening, antihypertensive therapy, prognosis
- MeSH terms
- Humans, Hypertension, Kidney Diseases, Prognosis, Risk Factors, Incidence, Prevalence, Hypertrophy, Left Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.